The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Abstract
With biotechnological advancements, innovative omics technologies are constantly emerging that have enabled researchers to access multi-layer information from the genome, epigenome, transcriptome, proteome, metabolome, and more. A wealth of omics technologies, including bulk and single-cell omics approaches, have empowered to characterize different molecular layers at unprecedented scale and resolution, providing a holistic view of tumor behavior. Multi-omics analysis allows systematic interrogation of various molecular information at each biological layer while posing tricky challenges regarding how to extract valuable insights from the exponentially increasing amount of multi-omics data. Therefore, efficient algorithms are needed to reduce the dimensionality of the data while simultaneously dissecting the mysteries behind the complex biological processes of cancer. Artificial intelligence has demonstrated the ability to analyze complementary multi-modal data streams within the oncology realm. The coincident development of multi-omics technologies and artificial intelligence algorithms has fuelled the development of cancer precision medicine. Here, we present state-of-the-art omics technologies and outline a roadmap of multi-omics integration analysis using an artificial intelligence strategy. The advances made using artificial intelligence-based multi-omics approaches are described, especially concerning early cancer screening, diagnosis, response assessment, and prognosis prediction. Finally, we discuss the challenges faced in multi-omics analysis, with tentative future trends in this field. With the increasing application of artificial intelligence in multi-omics analysis, we anticipate a shifting paradigm in precision medicine becoming driven by artificial intelligence-based multi-omics technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
Lieberman-Aiden, E., van Berkum, N. L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., Amit, I., Lajoie, B. R., Sabo, P. J., Dorschner, M. O., et al. (2009) · Science · doi:10.1126/science.1181369 · Cited by 8,898
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
A guide to deep learning in healthcare
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0316-z · Cited by 5,312
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
Evolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,208
Artificial intelligence in radiology
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. W. L. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0016-5 · Cited by 3,803
Capturing Chromosome Conformation
Dekker, J., Rippe, K., Dekker, M., & Kleckner, N. (2002) · Science · doi:10.1126/science.1067799 · Cited by 3,652
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Research works printed but not linked: 8
- Anderson, 2022, Spatial transcriptomics, Cancer Cell, 40, 895, 10.1016/j.ccell.2022.08.021 · doi:10.1016/j.ccell.2022.08.021
- Linnarsson, 2016, 17, 1
- Kann, 2021, Artificial intelligence for clinical oncology, Cancer Cell, 39, 916, 10.1016/j.ccell.2021.04.002 · DOI · Paper page
- Bhinder, 2021, Artificial intelligence in cancer research and precision medicine, Cancer Discov., 11, 900, 10.1158/2159-8290.CD-21-0090 · DOI · Paper page
- Ibrahim, 2022, Assessment of mitotic activity in breast cancer: revisited in the digital pathology era, J. Clin. Pathol., 75, 365, 10.1136/jclinpath-2021-207742 · DOI
- Wang, 2020, 172, 59
- T. Guo, T. Lin, N. Antulov-Fantulin, In Exploring interpretable lstm neural networks over multi-variable data, in: International Conference on Machine Learning, PMLR, 2019, pp 2494–2504.
- Chaudhary, 2018, Deep learning-based multi-omics integration robustly predicts survival in liver cancer, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 24, 1248, 10.1158/1078-0432.CCR-17-0853 · DOI · Paper page
Cited by
Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare
Mohr, A. E., Ortega-Santos, C. P., Whisner, C. M., Klein-Seetharaman, J., & Jasbi, P. (2024) · Biomedicines · doi:10.3390/biomedicines12071496 · Cited by 311
“This standard workflow in ML encompasses stages like data preprocessing, algorithm and model selection, training, testing, tuning, and validation [96].”
MethodTransforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice
Khera, R., Oikonomou, E. K., Nadkarni, G. N., Morley, J. R., Wiens, J., Butte, A. J., & Topol, E. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.003 · Cited by 264
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
Zhang, C., Xu, J., Tang, R., Yang, J., Wang, W., Yu, X., & Shi, S. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01514-5 · Cited by 148
Hsu, C.-Y., Askar, S., Alshkarchy, S. S., Nayak, P. P., Attabi, K. A. L., Khan, M. A., Mayan, J. A., Sharma, M. K., Islomov, S., & Soleimani Samarkhazan, H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01965-9 · Cited by 140
“Similarly, integrated omics classifiers have demonstrated robust diagnostic capabilities (AUC 0.81–0.87) for malignancies such as pancreatic can - cer where early detection remains challenging [ 17 , 22 ].”
InfluentialLukac, S., Dayan, D., Fink, V., Leinert, E., Hartkopf, A., Veselinovic, K., Janni, W., Rack, B., Pfister, K., Heitmeir, B., et al. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07130-5 · Cited by 130
“1 3 support establishing a more precise medicine, particularly in the days when a huge amount of data is available[17, 18].”
BackgroundMachine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota
Rozera, T., Pasolli, E., Segata, N., & Ianiro, G. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.035 · Cited by 112
Omics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
“Genomic alterations could also cause changes in metabolic profiles, and these changes eventually could facilitate cancer development [14].”
BackgroundInfluentialGeaney, A., O’Reilly, P., Maxwell, P., James, J. A., McArt, D., & Salto-Tellez, M. (2023) · Oncogene · doi:10.1038/s41388-023-02857-6 · Cited by 42
Goel, I., Bhaskar, Y., Kumar, N., Singh, S., Amanullah, M., Dhar, R., & Karmakar, S. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1550407 · Cited by 31
Wang, Y., Wang, Z., Yu, X., Wang, X., Song, J., Yu, D.-J., & Ge, F. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae658 · Cited by 25
“Significant advancements in diverse high-throughput sequencing methods, e.g. DNA nanosphere sequencing, mRNA expression (mRNA), DNA methylation (meth), and miRNA expression (miRNA), have fundamentally revolutionized various biological analyses and facilitated biological discoveries [1, 2].”
Exploring and bypassing resistance to targeted therapies in colorectal cancer
Favier, S., Xiong, W., Chalabi-Dchar, M., Chettab, K., Piercey, O., Wu, T., Fenouil, T., Albaret, M.-A., Jordheim, L. P., Diaz, J.-J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118741 · Cited by 12
Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review
Chen, S., Tu, L., & Chen, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1898418 · Cited by 1
“AI-driven analysis of single-cell and spatial data is also an emerging trend, with deep learning models being used to identify cell types, predict drug response, and infer gene regulatory networks (He et al., 2023).”
Metadata
- Authors
- He, X., Liu, X., Zuo, F., Shi, H., & Jing, J.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 88
- Pages
- 187-200
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W4313346475
- Cited by
- 445
- References
- 211
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- West China Hospital, Sichuan University
- National Natural Science Foundation of China (22105137, 81902792, 82172634)
- Sichuan University (ZYYC20013)
- Shaoxing Bureau of Science and Technology (2021YFSY0007)
- National Key Research and Development Program of China (2022YFC2504700, 2022YFC2504703)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.